logo
Select company
Select metric
$ 282.96MCore Assets
VS
Market
38
Sector
68
Industry
78
History
100
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information

Ticker

STOK

Company Name

STOKE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

STOKE THERAPEUTICS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STOK - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 384.51M$ 101.55M$ 282.96M$ 0
3/31/2025$ 406.89M$ 274.89M$ 132M$ 0
12/31/2024$ 271.56M$ 128.06M$ 143.5M$ 0
9/30/2024$ 293.32M$ 150.09M$ 143.23M$ 0
6/30/2024$ 307.76M$ 193.55M$ 114.21M$ 0
3/31/2024$ 205.18M$ 179.15M$ 26.03M$ 0
12/31/2023$ 228.34M$ 192.01M$ 36.33M$ 0
9/30/2023$ 239.89M$ 190.55M$ 49.34M$ 0
6/30/2023$ 256.92M$ 192.63M$ 64.29M$ 0
3/31/2023$ 281.8M$ 190.91M$ 90.89M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 8.27M.
  • Over the past 5 years, STOKE THERAPEUTICS INC's average Core Assets has been $ 108.76M.
  • The median Core Assets for STOKE THERAPEUTICS INC during this period was $ 99.59M
  • STOKE THERAPEUTICS INC reached its highest Core Assets over the past 5 years at $ 282.96M.
  • The lowest Core Assets recorded by STOKE THERAPEUTICS INC in the same timeframe $ 8.27M

STOKE THERAPEUTICS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
AKBA : AKEBIA THERAPEUTICS INC $ 149.24MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 463.81MDNA : GINKGO BIOWORKS HOLDINGS INC $ 961.29MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 304.56MGERN : GERON CORP $ 475.59MKROS : KEROS THERAPEUTICS INC $ 65.5MNAGE : NIAGEN BIOSCIENCE INC $ 30.77MCRMD : CORMEDIX INC $ 91.55MIOVA : IOVANCE BIOTHERAPEUTICS INC $ 472.77MPHAT : PHATHOM PHARMACEUTICALS INC $ 97.79M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for STOKE THERAPEUTICS INC is calculated as follows: Assets [ $ 199.94M ] - Intangibles [ $ 0 ] - CashnEq [ $ 191.67M ]
(=) Core Assets [ $ 8.27M ]

STOK - Core Assets, Last 5 years

$ 8.27M

Minimum

Sep 30, 2020

$ 282.96M

Maximum

Jun 30, 2025

$ 108.76M

Average

$ 99.59M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.38M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.38M
median$ 287.61M
std$ 1.05B